Clonal dissemination of KPC-2 producing  ST11 clone with high prevalence of  and  in a tertiary hospital in China: results from a 3-year period by unknown
Cheng et al. Ann Clin Microbiol Antimicrob  (2016) 15:1 
DOI 10.1186/s12941-015-0109-x
RESEARCH
Clonal dissemination of KPC-2 
producing Klebsiella pneumoniae ST11 clone 
with high prevalence of oqxAB and rmtB in a 
tertiary hospital in China: results from a 3-year 
period
Li Cheng†, Xiao‑Li Cao†, Zhi‑Feng Zhang, Ming‑zhe Ning, Xue‑Jing Xu, Wanqing Zhou, Jun‑Hao Chen, 
Jin‑hua Zhang, Han Shen* and Kui Zhang*
Abstract 
Background: Carbapenemase‑producing Klebsiella pneumoniae (CPKP) strains have emerged as a major problem for 
healthcare systems. The aim of this study was to determine the circulating clones and analyze the clinical and molecu‑
lar characteristics of CPKP in our hospital.
Methods: A total of 74 carbapenemase producers collected from our hospital from 2012 to 2014 were analyzed for 
the prevalence of extended‑spectrum β‑lactamase (ESBLs), plasmid‑mediated quinolone resistance genes (PMQRs), 
exogenously acquired 16S rRNA methyltransferase (16S‑RMTase), and plasmid‑mediated AmpC enzyme (pAmpCs) by 
PCR and DNA sequencing. The sequence types (STs) of the carbapenemase producers were analyzed by multi‑locus 
sequence typing (MLST). And Pulsed‑field gel electrophoresis (PFGE) was performed to investigate the genetic rela‑
tionship of KPC‑2 producing strains. Clinical data were retrieved from the medical records.
Results: KPC‑2 (n = 72) was the predominant enzyme followed by NDM‑1 (n = 2); The genes blaCTX‑M, blaSHV, 
blaTEM‑1, blaDHA‑1, rmtB, armA, oqxA, oqxB, and qnrB were present in 29 (39.2 %), 27 (36.5 %), 46 (62.2 %), 2 (2.7 %), 25 
(33.8 %), 1 (1.4 %), 60 (81.1 %) and 56 (75.7 %), 6 (8.1 %) isolates, respectively. MLST analysis revealed 10 different STs. 
The most dominant ST was ST11 (78.4 %, 58/74), followed by ST15 (8.1 %, 6/74). PFGE patterns of the KPC‑2 produc‑
ing K. pneumoniae isolates exhibited clonal dissemination of ST11 and ST15 clones as well as a genetic diversity of the 
remaining strains.
Conclusion: The intra‑ and inter‑hospital cross‑transmission of KPC‑2‑producing K. pneumoniae ST11 co‑carrying 
oqxAB and rmtB in our hospital strongly suggested that rapid identification of colonized or infected patients and 
screening of carriers is quite necessary to prevent a scenario of endemicity.
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Background
Klebsiella pneumoniae are part of the human gut micro-
biota and frequently cause infections from mild urinary 
and gastrointestinal infections to severe bacteremia and 
pneumonia with a high rate of mortality and morbidity 
[1]. An increasing emergence of carbapenem resistance 
among K. pneumoniae isolates worldwide has limited the 
therapeutic options for treatment of these infections [2].
Carbapenem resistance in K. pneumoniae is frequently 
caused by the predominant production of KPC carbap-
enemase worldwide [3], the production of OXA-48-like 
carbapenemase is currently spreading most rapidly in 
many European countries with IMP and VIM being occa-
sionally detected [4]. And transmission of blaNDM are 
potentially global health issues [5]. In addition, Carriage 
of blaESBL and/or blaAmpC in combination with active 
efflux or porin loss has also been shown to be responsible 
for carbapenem-resistance in Enterobacteriaceae [6].
Carbapenem resistant K. pneumoniae (CRKP) is 
reported to be caused either by epidemic clones or by 
the horizontal dissemination of mobile elements such as 
plasmids and insertion sequences. In Europe and Ameri-
can countries, KPC-producing ST258  K. pneumoniae 
can undeniably be regarded as one of the most successful 
multidrug-resistant nosocomial pathogens [7]. And the 
international high-risk clone of K. pneumoniae ST11 is 
frequently reported as a successful pathogen at infections 
in Asian and European countries because of the associa-
tion of important co-resistance and virulence factors [8]. 
And the quick expansion and evolution of this multi-
resistant and virulent clone may lead to an evolving crisis 
of global dimensions [9].
In recent years, CRKP has been emerging with an 
increasing frequency worldwide [2]. All these isolates 
were resistant to currently available antimicrobial agents 
except tigecycline. Extended-spectrum β-lactamase 
(ESBLs), exogenously acquired 16S rRNA methyltrans-
ferase (16S-RMTase) genes, and plasmid-mediated 
AmpC enzyme (pAmpCs) has been frequently detected 
among the clinical multidrug-resistant Enterobacte-
riaceae [10]. In addition, the prevalence of PMQR genes 
has been reported to be associated with the increasing 
quinolone resistance development in Enterobacteriaceae 
which involved an increase in the diversity of the PMQR 
genes [11]. Nevertheless, data on the distribution of these 
resistant determinants among carbapenemase-producing 
K. pneumoniae (CPKP) isolates collected during a long 
time period is still limited, and the dissemination of the 
internationally predominant CPKP isolate is still unclear.
The aim of the present study was to determine the 
circulating clones of CPKP and our study focused on a 
hospital-wide screening of ESBLs, 16S-RMTase, PMQRs 




Nanjing Drum Tower hospital is comprehensive tertiary 
hospital which manages 32 clinical departments, main-
tains 1460 patients, and admits more than 42,000 inpa-
tients. A total of 108 non-replicate and consecutive K. 
pneumoniae isolates including 107 CRKP and 1 strains 
intermediate to carbapenem were collected from our 
hospital from January, 2012 to December, 2014. The Vitek 
2 system (bioMérieux. Firenze, Italy) was used for isolate 
identification and antimicrobial drug susceptibility test-
ing. Clinical specimens consisted of sputum (n  =  44), 
blood (n = 18), urine (n = 12), secretion (n = 11), ascites 
(n  =  9), bile (n  =  6) catheter tips (n  =  6), and others 
(n  =  2). Among them, carbapenemase producers were 
further analyzed in this study. Clinical data such as the 
clinical features, laboratory results, and treatment were 
retrieved from the medical records department. The 
study protocol was approved by the Ethics Committee 
of Nanjing Drum Tower Hospital and written informed 
consent was obtained from all patients included in the 
study.
Carba NP confirmatory test
For carbapenemase detection, Carba NP Confirma-
tory test was performed on 108  K. pneumoniae isolates 
according to the guidelines of Nordmann et al. [12] and 
CLSI 2015 [13]. Briefly, 2 microcentrifuge tubes for 
each patient isolate were labelled as “a” and “b” with 100 
μL of bacterial protein extraction reagent (Tris–HCl 
20  mmol/L lysis buffer) being added into each tube. A 
1-μL loopful of tested bacteria from an overnight blood 
agar plate was emulsified in both tubes and vortexed 
for 5  s. Carba NP Solution A (2  mL 0.5  % phenol red 
solution and 180 μL 10  mM zinc sulfate solution were 
added into 16.6 mL clinical laboratory reagent water, pH 
7.8 ±  0.1) was added into tube “a” and Carba NP Solu-
tion B (solution A + 6 mg/mL imipenem) into tube “b”, 
respectively. After the tubes were well vortexed, An incu-
bation at 35 ± 2 °C for up to 2 h was needed. Test results 
were interpreted as follows: carbapenemase producers 
were reported when tube “b” became into light-orange, 
dark yellow, or yellow before 2 h, and tube “a” kept red or 
red–orange.
ESBLs confirmatory testing
ESBL production was detected by using the 2015 CLSI 
recommendations for phenotypic confirmatory test 
[13]. In brief, disks containing 30  μg of cefotaxime and 
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ceftazidime, either alone or coupled with 10  μg of cla-
vulanate (Oxoid Ltd, Cambridge, UK), were placed at 
distances of 20 mm (center to center). When the inhibi-
tion zone differed by ≥5  mm, between at least 1 of the 
combination disks and its corresponding single antibiotic 
disk, the strain was identified as an ESBL producer. E. 
coli ATCC 25922 and K. pneumoniae ATCC 700603 were 
used as quality control strains.
Detection of antimicrobial resistance determinants
DNA templates were prepared by the boiling method. 
All the 108 strains were screened for blaOXA-48 and 
blaNDM genes by PCR as previously described [14]. The 
74 carbapenemase-producers identified by Carba NP 
Confirmatory test were further analyzed for carbapene-
mase encoding genes (blaKPC, blaIMI, blaSME, blaGES, 
blaVIM, blaIMP, blaNDM, blaGIM) by PCR-based tech-
niques with subsequent sequencing according to the pro-
tocols as previously described [15], PMQRs (qnrA, qnrB, 
qnrC, qnrD, qnrS, aac (6′)-Ib-cr, and qepA) were detected 
by simplex PCR, followed by sequencing [16]. Among 
the 74 carbapenemase-producing strains, the presence 
of blaESBLs (blaCTX, blaTEM, blaSHV) were checked 
for 42 strains positive for the ESBLs confirmatory testing 
according to the previous protocol [17], The 50 strains 
resistant to amikacin were further analyzed for the preva-
lence of 16S-RMTases (armA, npmA, rmtA, rmtB, rmtC, 
rmtD, and rmtE) [18] by multiplex PCR followed by sin-
gle PCR for gene confirmation. Positive products were 
further purified with a DNA purification kit and then 
sent to the Majorbio Company (Shanghai, China) for 
sequencing. Sequences were analyzed by using the Chro-
mas-Pro application and BLAST (http://www.ncbi.nlm.
nih.gov/BLAST), and the subtypes of β-lactamase genes 
were confirmed by referring to the Lahey system (http://
www.lahey.org/studies/).
Multi‑locus sequence typing
The sequence types of the 74 carbapenemase producers 
were determined by multi-locus sequence typing (MLST) 
analysis with 7 housekeeping genes including gapA, 
infB, mdh, pgi, phoE, rpoB, and tonB being amplified and 
sequenced according to Diancourt et al. [19]. Alleles and 
sequence types (STs) were assigned by using the MLST 
database (http://www.pasteur.fr/mlst/Kpneumoniae.html).
Pulsed‑field gel electrophoresis
Clonal relatedness of the 72 producing KPC-2  K. pneu-
moniae strains was analyzed by pulsed-field electropho-
resis (PFGE) as previously described [20]. The restriction 
endonuclease XbaI (Fermentas, ABI, Germany) was used 
to digest the prepared genomic DNA and resultant DNA 
fragments were separated in a PFGE CHEF-DR III system 
(Bio-Rad Laboratories, Hercules, CA, USA) in 0.5× Tris–
borate-EDTA buffer at 120 V for 19 h, with pulse times 
ranging from 2.2 to 54.2  s. The banding patterns were 
analyzed by the BioNumerics software (Applied Math, 
Sint-Maten-Latem, Belgium). Cutoff lines at 80  % were 
used to analyze genetic relatedness.
Results
Prevalence of carbapenemase and Antimicrobial 
susceptibility of CPKP isolates
Carba NP Confirmatory test showed that 74 out of 108 
carbapenem resistant K. pneumoniae isolates were 
confirmed to be carbapenemase producers. PCR and 
molecular typing identified KPC-2 among 72 out of 74 
carbapenemase producers and the other 2 isolates was 
found to produce NDM-1. Other carbapenemase-encod-
ing genes were not detected. All the 74 carbapenemase 
producers found in our study were resistant to all of the 
β-lactams tested with 67.6 % (50/74) exhibiting resistance 
to amikacin and 72.73 % (54/74) exhibiting resistance to 
quinolones.
Clinical characteristics of CPKP isolates
A total of 15 departments in our hospital have been 
involved with the clonal dissemination of KPC-2 produc-
ing K. pneumoniae isolates in our hospital with the inten-
sive care units (ICU) being the commonest department 
(n  =  21), followed by Emergency (n  =  10) and Depart-
ment of Neurosurgery (n = 9). Departments of Geriatrics 
and General Surgery, Infectious Diseases, Otolaryngology, 
Urology, Respiratory, Hematology, Neurology, Cardio-
thoracic, and Cardiology have also been included. The 
isolates were mainly from the respiratory tract (n =  35), 
blood (n =  12) and urine (n =  8). Overall, the spread of 
KPC-2 producing K. pneumoniae ST11 clones co-carrying 
other resistance genes in hospital wards during 2012–2014 
(Table 1) showed that compared to the data in 2012, such 
strains rapidly increased with more hospital wards being 
involved, especially in ICU. And a rapid decrease of such 
strains was observed during 2014 resulting from the 
strengthening implementation of hand hygiene in our 
hospital at the beginning of 2014 (personal communica-
tion). In addition, the Retrieval of NDM-producing K. 
pneumoniae strains showed that one strain was isolated 
from the blood of a 61-year-old male diagnosed as elec-
trolyte imbalance after colorectal cancer surgery since he 
was admitted into ICU, persistent fever and blood culture 
showed severe septicemia caused by a NDM-producing 
K. pneumoniae strain, after a combination therapy of imi-
penem, tigecycline, and cefepime for 20 days, the patient 
died; the other NDM-producing K. pneumoniae was 
recovered from the secretion of a 41-year-old male who 
had undergone a serious burns on his whole body. No 
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fever was observed although NDM-producing K. pneumo-
niae was isolated from the burn wounds of the patients. 
After a series of Rinse debridement treatment, the patient 
got a good wound healing and discharged.
Prevalence of antimicrobial resistant determinants
ESBLs confirmatory testing showed that 42 strains were 
positive for ESBLs among the 74 carbapenemase-produc-
ing strains. PCR and DNA sequencing identified CTX-
M, SHV, and TEM-1 type β-lactamases in 29 (39.2  %), 
27 (36.5  %), 46 (62.2  %) isolates, respectively. CTX-M 
variants included 24 CTX-M-14, 3 CTX-M-15, 2 CTX-
M-38; one SHV-1 and multiple SHV variants includ-
ing SHV-11 (n = 2), SHV-12 (n = 13), SHV-28 (n = 2), 
SHV-31 (n = 6), SHV-160 (n = 2), and SHV-36a (n = 1) 
were observed. In addition, 2 DHA-1 were identified. 
16S-RMTase including RmtB (n = 25) and Arm (n = 1) 
were identified among 26 out of the 50 carbapenemase-
producers displaying resistance to amikacin. Fifty out of 
74 carbapenemase producers were found to carry oqxAB. 
And the prevalence of both oqxA and oqxB detected in 
K. pneumoniae was high: 83.3 and 77.8  %, respectively. 
Of them, 48 oqxAB, 58 oqxA and 56 oqxB were detected 
among 69 carbapenemase producers highly resistant to 
fluoroquinolones. Whereas, 2 oqxAB, 2 oqxA and 2 oqxB 
were found among the 3 carbapenemase producers sus-
ceptible to fluoroquinolones.
In addition, one novel mutants named oqxA11 and 3 
novel oqxB mutants named oqxB13, oqxB27, and oqxB28 
were identified. And 3 kinds of qnrB variants including 
qnrB6 (n = 1), qnrB10 (n = 3) and qnrB66 (n = 2) were 
identified. Other PMQRs were not detected.
Of particular concern, qnrB6, oqxA, blaTEM-1, and 
blaCTX-M-15 were identified in one NDM-producing iso-
late, albeit only oqxB, NDM-1 was found in the other one.
MLST
MLST analysis of 74 carbapenemase producers revealed 
10 different STs (Fig.  1). The most dominant ST was 
ST11 (78.4 %, 58/74), followed by ST15 (8.1 %, 6/74). The 
remaining isolates were typed as ST23, ST218, ST362, 
ST412, ST420, ST606, ST690, and ST709. MLST analysis 
of 2 NDM-1 producing K. pneumoniae isolates identified 
as ST826 and ST307, respectively.
Clonal relatedness
According to the PFGE patterns of the isolates (Fig.  1), 
the 57 KPC-2 producing K. pneumoniae ST11 isolates 
exhibited 7 PFGE profiles. One major clonal groups com-
posed of 47 closely related strains was observed among 
all the ST11 clones according to the 80 % similarity level. 
The PFGE data of the other 13 KPC-2 producing K. pneu-
moniae displayed a genetic diversity (Fig.  2). Among 
them, 2 PFGE profiles composed of 5 ST15 clones were 
observed. In addition, 2 strains including 1 ST11 clone 
and 1 ST15 one were non-typable by PFGE.
Discussion
Clonal dissemination of CRKP in the health care settings 
frequently cause a potential threat to the public health 
with the increasing use of carbapenems in the clinical 
treatments worldwide. And we provided the first report 
on the clonal dissemination of K.  pneumoniae ST11 
with a high prevalence of OqxAB in a tertiary hospital in 
China.
In this study, 72 out of 74 carbapenemase producers 
carried KPC-2, indicating that KPC is the major CHBLs 
accounting for the carbapenem resistance and KPC-2 
is the most prevalent enzyme which was in accordance 
with the previous studies both at home and abroad [3]. 
OqxAB, encoded by both chromosome and plasmids as 
a quinolone and olaquindox efflux pump, has become 
increasingly prevalent among members of Enterobacte-
riaceae over the past decade [21, 22]. It has been demon-
strated that acquisition of the oqxAB encoding plasmids 
may facilitate the selection of CIP resistant Salmonella 
typhimuriu [23], and high expression of this pump con-
tributes to reduced susceptibility to quinolones in clinical 
Table 1 The spread of  KPC-2 producing K. pneumonia ST11 clones associated with  other resistance genes in  hospital 
wards during 2012–2014
KPK-ST11: KPC-2 producing K. pneumonia ST11
ER emergency room, ICU Intensive Care Unit, CS cardiothoracic surgery, NL neurology, AD andrology, UL urology, VS vascular surgery, NS neurosurgery, GS general 
surgery, GA geriatrics, RP respiratory, IDS infectious diseases, OG Otolaryngology
Isolation  
year
KPK‑ST11 Antimicrobial Resistance determinants Ward
ESBLs PMQRs 16S‑RMTase Carbapenemase AmpC
2012 10 8 10 7 10 0 ER(3), GS(2), NL(1), GA(1), NS(1), RP(1), VS(1)
2013 36 33 32 13 36 1 ICU(11), NS(6), ER(6), GS(3) GA(2), IDS(1), 
OG(1), UL(1), RP(1)
2014 11 8 9 1 11 1 ICU(4), CS(3), AD(1), GA(1), NS(1)
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Fig. 1 Dendrogram based on PFGE profiles of 57 KPC‑2 producing K. pneumoniae ST11 isolates. The dendrogram was produced by the UPGMA 
algorithm based on the Dice similarity coefficient included five PFGE groups as defined based on 80 % similarity of PFGE profiles. ID isolation date, 
Ss samples, RDs resistant determinants, ER emergency room, ICU Intensive Care Unit, CS cardiothoracic surgery, NL neurology, AD andrology, UL urol‑
ogy, VS vascular surgery, NS neurosurgery, GS general surgery, GA geriatrics, RP respiratory, IDS infectious diseases, OG otolaryngology
Page 6 of 8Cheng et al. Ann Clin Microbiol Antimicrob  (2016) 15:1 
isolates of ESBL-producing K. pneumoniae [24]. A more 
recently published paper also described that overexpres-
sion of the oqxAB efflux pump in K. pneumoniae has 
been linked to an antibiotic cross-resistance phenotype 
[25] and OqxAB may contribute to tigecycline resistance 
in K. pneumoniae isolates [26]. Furthermore, a previous 
analysis of the genotypic and phenotypic characteristics 
of K. pneumoniae harboring oqxAB-like elements found 
that chromosomal oqxAB elements in K. pneumoniae 
strains exhibited cross resistance to olaquindox, chlo-
ramphenicol and the quinolones, whereas, transposition 
of the oqxAB operon from bacterial chromosome to plas-
mids results in more than 80-fold increase in the level of 
expression of the oqxAB pump, confirming that oqxAB 
efflux system is constitutively expressed when located in 
bacterial mobile elements [27]. The resistance mediated 
by the mutations in the quinolone-resistance determin-
ing regions in DNA gyrase and DNA topoisomerase IV 
of K. pneumoniae makes it difficult for us to speculate 
whether oqxAB in our study locates on plasmids or on 
the chromosome, and further study is needed to analyze 
the locations of these oqxAB operons and the role that 
oqxAB, oqxA and oqxB played in the fluoroquinolone 
development.
All together, the observed high prevalence of pump 
gene oqxA and oqxB in combination or alone in the 
KPC-2 producing K. pneumoniae ST11 represents a 
potential reservoir for the spread of these genes.
Of note, it’s the first time that we identified a new vari-
ant qnrB66 as well as the novel mutant named oqxA11 
and 3 novel oqxB mutants named oqxB13, oqxB27, and 
oqxB28 in K. pneumoniae which indicate that these 
PMQRs have been rapidly evolving under the selec-
tion pressure of antimicrobial agents in the healthcare 
settings.
Furthermore, the high prevalence of rmtB among 
KPC-2 producing K. pneumoniae isolates has been 
reported in China [28], it has also been characterized that 
rmtB and blaKPC-2 were located in the same plasmid and 
frequently disseminated among K. pneumoniae isolates 
under the selection pressure of antimicrobial agents [29].
Up to date, ST11 strains has been frequently reported 
to be the carriage of multiple resistant determinants 
such as CTX-M, KPC-2, as well as RmtB [8]. And the co-
carriage of different ESCs (extended-spectrum cephalo-
sporinaes) and 16S-RMTases, alone or in combination, 
were also noted among the KPC-2 isolates in our study, 
indicating that the clone dissemination of ST11 strain 
may carry different types of plasmids or more than one 
plasmid. Additionally, recent reports showed that ST11 is 
the dominant strain associated with carbapenem resist-
ance in K. pneumoniae [30] and even also the predomi-
nant clone of tigecycline-resistant K. pneumoniae strains 
[26], indicating that K. pneumoniae ST11 has been devel-
oping as major high-risk clone. Taken together, these data 
indicated rapid evolution and expansion of the KPC-2 
producing ST11 isolates with acquisition and spread of 
transferable resistance determinants in our hospital [31].
Noticeably, there is a potential dissemination of ST15 
clone secondary to the ST11 clones in our study, indicat-
ing that ST15 is another major high-risk clones. This is 
consistent with a recent study [32]. ST23 has been fre-
quently reported to be the carbapenem resistant strains 
[33], whereas, the other clones including ST218, ST362, 
ST412, ST420, ST606, ST690, and ST709 has not been 
reported to be involved with carbapenem resistance.
Of particular concern, NDM has been frequently 
found in K. pneumoniae isolates and involved with the 
healthcare associated outbreaks in China [34, 35] and 
the emergence of NDM-producing K. pneumoniae 
Fig. 2 Dendrogram based on PFGE profiles of 13 KPC‑2 producing K. pneumoniae isolates. The dendrogram was produced by the UPGMA algo‑
rithm based on the Dice similarity coefficient included five PFGE groups as defined based on 80 % similarity of PFGE profiles. ID isolation date, Ss 
samples, RDs resistant determinants, ER emergency room, UL urology, GE gastroenterology, NS neurosurgery, RP respiratory, NL neurology, BS burn 
surgery, ER emergency room, CL cardiology, GA geriatrics, ICU Intensive Care Unit, GS general surgery
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isolates in our hospital showed a spread potential of 
these strains and infection control measures should be 
emergently implemented to prevent the healthcare asso-
ciated outbreaks since the choice of antimicrobial agents 
is quite limited once the patients were infected with 
NDM-producing K. pneumoniae isolates. Additionally, 
to the best of our knowledge, it’s the first time that we 
provide data on the K. pneumoniae ST826 and ST307 
clones carrying NDM.
In recent years, the clonal dissemination of CRKP ST11 
among Chinese hospitals has been frequently reported 
[32] and the wide distribution of the KPC-2-producing 
K. pneumoniae ST11 isolates co-carrying oqxAB and 
rmtB in our study indicate an intra- and inter- hospital 
cross-transmission of such strains in our hospital, which 
further strongly suggested that these isolates have a high 
potential to cause healthcare-associated outbreaks. Care-
ful monitoring of carbapenem susceptibilities and rapid 
identification of colonized or infected patients as well as 
screening of carriers is quite necessary for implementa-
tion of infection control measures to prevent a scenario 
of endemicity.
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